Eintrag weiter verarbeiten
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study
Gespeichert in:
Zeitschriftentitel: | Therapeutic Advances in Neurological Disorders |
---|---|
Personen und Körperschaften: | , , , , , , , |
In: | Therapeutic Advances in Neurological Disorders, 11, 2018, S. 175628561775336 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
SAGE Publications
|
Schlagwörter: |
author_facet |
Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin |
---|---|
author |
Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin |
spellingShingle |
Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin Therapeutic Advances in Neurological Disorders Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study Neurology (clinical) Neurology Pharmacology |
author_sort |
comi, giancarlo |
spelling |
Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin 1756-2864 1756-2864 SAGE Publications Neurology (clinical) Neurology Pharmacology http://dx.doi.org/10.1177/1756285617753365 Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study Therapeutic Advances in Neurological Disorders |
doi_str_mv |
10.1177/1756285617753365 |
facet_avail |
Online Free |
finc_class_facet |
Medizin Chemie und Pharmazie |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg1NjE3NzUzMzY1 |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg1NjE3NzUzMzY1 |
institution |
DE-L229 DE-D275 DE-Bn3 DE-Brt1 DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 |
imprint |
SAGE Publications, 2018 |
imprint_str_mv |
SAGE Publications, 2018 |
issn |
1756-2864 |
issn_str_mv |
1756-2864 |
language |
English |
mega_collection |
SAGE Publications (CrossRef) |
match_str |
comi2018longtermeffectsofcladribinetabletsonmriactivityoutcomesinpatientswithrelapsingremittingmultiplesclerosistheclarityextensionstudy |
publishDateSort |
2018 |
publisher |
SAGE Publications |
recordtype |
ai |
record_format |
ai |
series |
Therapeutic Advances in Neurological Disorders |
source_id |
49 |
title |
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_unstemmed |
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_full |
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_fullStr |
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_full_unstemmed |
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_short |
Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_sort |
long-term effects of cladribine tablets on mri activity outcomes in patients with relapsing–remitting multiple sclerosis: the clarity extension study |
topic |
Neurology (clinical) Neurology Pharmacology |
url |
http://dx.doi.org/10.1177/1756285617753365 |
publishDate |
2018 |
physical |
175628561775336 |
description |
|
container_start_page |
0 |
container_title |
Therapeutic Advances in Neurological Disorders |
container_volume |
11 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792342322212503558 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T16:33:58.781Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Long-term+effects+of+cladribine+tablets+on+MRI+activity+outcomes+in+patients+with+relapsing%E2%80%93remitting+multiple+sclerosis%3A+the+CLARITY+Extension+study&rft.date=2018-01-01&genre=article&issn=1756-2864&volume=11&pages=175628561775336&jtitle=Therapeutic+Advances+in+Neurological+Disorders&atitle=Long-term+effects+of+cladribine+tablets+on+MRI+activity+outcomes+in+patients+with+relapsing%E2%80%93remitting+multiple+sclerosis%3A+the+CLARITY+Extension+study&aulast=Giovannoni&aufirst=Gavin&rft_id=info%3Adoi%2F10.1177%2F1756285617753365&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792342322212503558 |
author | Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin |
author_facet | Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin, Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin |
author_sort | comi, giancarlo |
container_start_page | 0 |
container_title | Therapeutic Advances in Neurological Disorders |
container_volume | 11 |
description | |
doi_str_mv | 10.1177/1756285617753365 |
facet_avail | Online, Free |
finc_class_facet | Medizin, Chemie und Pharmazie |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE3Ny8xNzU2Mjg1NjE3NzUzMzY1 |
imprint | SAGE Publications, 2018 |
imprint_str_mv | SAGE Publications, 2018 |
institution | DE-L229, DE-D275, DE-Bn3, DE-Brt1, DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1 |
issn | 1756-2864 |
issn_str_mv | 1756-2864 |
language | English |
last_indexed | 2024-03-01T16:33:58.781Z |
match_str | comi2018longtermeffectsofcladribinetabletsonmriactivityoutcomesinpatientswithrelapsingremittingmultiplesclerosistheclarityextensionstudy |
mega_collection | SAGE Publications (CrossRef) |
physical | 175628561775336 |
publishDate | 2018 |
publishDateSort | 2018 |
publisher | SAGE Publications |
record_format | ai |
recordtype | ai |
series | Therapeutic Advances in Neurological Disorders |
source_id | 49 |
spelling | Comi, Giancarlo Cook, Stuart Rammohan, Kottil Soelberg Sorensen, Per Vermersch, Patrick Adeniji, Abidemi K. Dangond, Fernando Giovannoni, Gavin 1756-2864 1756-2864 SAGE Publications Neurology (clinical) Neurology Pharmacology http://dx.doi.org/10.1177/1756285617753365 Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study Therapeutic Advances in Neurological Disorders |
spellingShingle | Comi, Giancarlo, Cook, Stuart, Rammohan, Kottil, Soelberg Sorensen, Per, Vermersch, Patrick, Adeniji, Abidemi K., Dangond, Fernando, Giovannoni, Gavin, Therapeutic Advances in Neurological Disorders, Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study, Neurology (clinical), Neurology, Pharmacology |
title | Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_full | Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_fullStr | Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_full_unstemmed | Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_short | Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
title_sort | long-term effects of cladribine tablets on mri activity outcomes in patients with relapsing–remitting multiple sclerosis: the clarity extension study |
title_unstemmed | Long-term effects of cladribine tablets on MRI activity outcomes in patients with relapsing–remitting multiple sclerosis: the CLARITY Extension study |
topic | Neurology (clinical), Neurology, Pharmacology |
url | http://dx.doi.org/10.1177/1756285617753365 |